$6.50
0.12[1.88%]
At close: Apr 19
$6.50
0[0.00%]
After Hours: 5:44PM EDT
Larimar Therapeutics
(NASDAQ:LRMR)Larimar Therapeutics Stock (NASDAQ:LRMR), Quotes and News Summary
Larimar Therapeutics Stock (NASDAQ: LRMR) stock price, news, charts, stock research, profile.
| Open | $6.310 |
| Close | $6.530 |
| Volume / Avg. | 509.318K / 623.947K |
| Day Range | 6.180 - 6.800 |
| 52 Wk Range | 2.180 - 13.680 |
| Market Cap | $414.700M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 36 |
| Short Interest | 6.96% |
| Days to Cover | 5.51 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Larimar Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Larimar Therapeutics (LRMR) stock?
You can purchase shares of Larimar Therapeutics (NASDAQ: LRMR) through any online brokerage.
Who are Larimar Therapeutics's (LRMR) competitors?
Other companies in Larimar Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Voyager Therapeutics (NASDAQ:VYGR), Replimune Group (NASDAQ:REPL), PepGen (NASDAQ:PEPG) and CareDx (NASDAQ:CDNA).
What is the target price for Larimar Therapeutics (LRMR) stock?
The latest price target for Larimar Therapeutics (NASDAQ: LRMR) was reported by Leerink Partners on Wednesday, April 3, 2024. The analyst firm set a price target for 25.00 expecting LRMR to rise to within 12 months (a possible 284.62% upside). 11 analyst firms have reported ratings in the last year.
Current Stock Price for Larimar Therapeutics (LRMR)?
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $6.5 last updated April 19, 2024 at 5:44 PM EDT.
Does Larimar Therapeutics (LRMR) pay a dividend?
There are no upcoming dividends for Larimar Therapeutics.
When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?
Larimar Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
Is Larimar Therapeutics (LRMR) going to split?
There is no upcoming split for Larimar Therapeutics.
What sector and industry does Larimar Therapeutics (LRMR) operate in?
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.